Literature DB >> 2425444

Immunotherapy trials: current status and future directions with special emphasis on biologic drugs.

A Hollinshead.   

Abstract

Mesh：

Substances：

Year:  1986        PMID： 2425444     DOI： 10.1007/bf00201907

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  33 in total

1.  Pilot trial of murine monoclonal antibodies in patients with advanced melanoma.

Authors:  G E Goodman; P Beaumier; I Hellström; B Fernyhough; K E Hellström
Journal:  J Clin Oncol       Date:  1985-03       Impact factor: 44.544

Review 2.  Tuftsin, a natural activator of phagocyte cells: an overview.

Authors:  V A Najjar
Journal:  Ann N Y Acad Sci       Date:  1983       Impact factor: 5.691

Review 3.  Suppressor T cells and the immune response to tumors.

Authors:  S Schatten; R D Granstein; J A Drebin; M I Greene
Journal:  Crit Rev Immunol       Date:  1984       Impact factor: 2.214

Review 4.  Immunology of metastasis. Can the immune response cope with disseminated tumor?

Authors:  P Frost; R S Kerbel
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

5.  Comparison of the efficacy of intravesical Bacillus Calmette-Guérin with thiotepa, mitomycin C, poly I:C/poly-L-lysine and cis platinum in murine bladder cancer.

Authors:  A Shapiro; T L Ratliff; D M Oakley; W J Catalona
Journal:  J Urol       Date:  1984-01       Impact factor: 7.450

6.  Production of large quantities of human immunoglobulin in the ascites of athymic mice: implications for the development of anti-human idiotype monoclonal antibodies.

Authors:  P G Abrams; J J Ochs; S L Giardina; A C Morgan; S B Wilburn; A R Wilt; R K Oldham; K A Foon
Journal:  J Immunol       Date:  1984-04       Impact factor: 5.422

7.  Preincubation of donor bone marrow cells with a combination of murine monoclonal anti-T-cell antibodies without complement does not prevent graft-versus-host disease after allogeneic marrow transplantation.

Authors:  P J Martin; J A Hansen; E D Thomas
Journal:  J Clin Immunol       Date:  1984-01       Impact factor: 8.317

8.  Monoclonal antibodies to myeloid differentiation antigens: in vivo studies of three patients with acute myelogenous leukemia.

Authors:  E D Ball; G M Bernier; G G Cornwell; O R McIntyre; J F O'Donnell; M W Fanger
Journal:  Blood       Date:  1983-12       Impact factor: 22.113

Review 9.  Transfusion therapy with platelets and leukocytes.

Authors:  N L Luban
Journal:  Pediatr Ann       Date:  1983-06       Impact factor: 1.132

10.  Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigen.

Authors:  R C Bast; T L Klug; E Schaetzl; P Lavin; J M Niloff; T F Greber; V R Zurawski; R C Knapp
Journal:  Am J Obstet Gynecol       Date:  1984-07-01       Impact factor: 8.661
View more
  2 in total

1.  An assessment of the effects of swainsonine on survival of mice injected with B16-F10 melanoma cells.

Authors:  M J Humphries; K Matsumoto; S L White; R J Molyneux; K Olden
Journal:  Clin Exp Metastasis       Date:  1990 Jan-Feb       Impact factor: 5.150

2.  Postoperative active specific immunization in curatively resected colorectal cancer patients with a virus-modified autologous tumor cell vaccine.

Authors:  B Lehner; P Schlag; W Liebrich; V Schirrmacher
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.